Paediatric respiratory diseases
Respiratory critical care
Sleep and breathing disorders
PG1 Postgraduate course
Part II: Outcomes in Central Sleep apnea (CSA) and hypoventilation syndromes
Clinical
Aims : The hypoventilation syndromes represent a variety of disorders that affect central ventilatory control, respiratory mechanics, or both. Obesity hypoventilation syndrome is a clinically important disorder with serious cardiovascular and metabolic consequences, increased morbidity and mortality, if unrecognized. CSA represents also a variety of disorders and/or results from various diseases, have a negative impact on patient prognosis depending also in the severity of underlying disease. HF patients with CSA are highly heterogeneous group with clinical relevant subgroups which has different prognosis and treatment response. This course aim to summarize the current knowledge regarding the: 1. early recognition and effective hypoventilation treatment using various currently available treatment modalities with the scope to improve patient-centered outcomes. 2. different clinical phenotypes of CSA in Heart failure (HF) patients , their correlation with prognosis and their relevance for identifying individualized therapeutic strategies targeted to improve morbidity and mortality and in general to improve patient-centered outcomes, 3. Early recognition and effective pre and post operative management of a patient with SDB, use of anaesthetics, towards patient safety and surgery outcomes, 4. Various types of sleep diagnostic test from type I to type IV and their use depending on patient profile, as well as their strengths and limitations.
Target audience :
Adult pulmonologist/Clinician, Clinical researcher, General practitioner, Medical Student, Medical Technical Assistant, Nurse, Respiratory critical care physician, Paediatrician, Pathologist, Patient, Physician in Pulmonary Training, Physiologist, Respiratory physiotherapist, Scientist (basic, translational), Respiratory therapist, Journalist
Methods :
Epidemiology, General respiratory patient care, Physiology
14:00
Clinical phenotypes in CSA: relevance for treatment decision and patients outcomes
W. Randerath(Solingen, Germany)
COI
-
Description
14:20
Discussion and Q&A
W. Randerath(Solingen, Germany)
COI
14:30
Obesity Hypoventilation Syndrome, one size dosen't fit all: which patient will benefit from various therapeutic options
J. Pépin(Grenoble, France)
COI
-
Description
14:50
Discussion and Q&A
J. Pépin(Grenoble, France)
COI
15:15
Pre and postoperative evaluation of patients with various forms of SDB: relevance of patient outcomes
Ö. Başoğlu(Izmir, Turkey)
COI
-
Description
15:35
Discussion and Q&A
Ö. Başoğlu(Izmir, Turkey)
COI
15:45
Type I to type IV diagnostic modalities: which one to choose according to various forms of SDB
R. Riha(Edinburgh (Edinburgh), United Kingdom)
COI
-
Description
16:05
Discussion and Q&A
R. Riha(Edinburgh (Edinburgh), United Kingdom)
COI
16:30
Group assignment
W. Randerath(Solingen, Germany)
COI
J. Pépin(Grenoble, France)
COI
Ö. Başoğlu(Izmir, Turkey)
COI
R. Riha(Edinburgh (Edinburgh), United Kingdom)
COI